# Lei Shi

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/lei-shi/

## Facts

| Field | Value |
| --- | --- |
| Citations | 23,433 |
| Field | COVID-19 Clinical Research Studies |
| h-index | 47 |
| i10-index | 96 |
| Last Known Institution | Nanchang University |
| OpenAlex ID | https://openalex.org/A5085715903 |
| ORCID iD | https://orcid.org/0000-0002-5727-3590 |
| Works | 223 |

## Researcher papers

- [A minimal common outcome measure set for COVID-19 clinical research](https://scholariq.org/papers/a-minimal-common-outcome-measure-set-for-covid-19-clinical-research/)
- [Fibroblast growth factor 21 improves hepatic insulin sensitivity by inhibiting mammalian target of rapamycin complex 1 in mice](https://scholariq.org/papers/fibroblast-growth-factor-21-improves-hepatic-insulin-sensitivity-by-inhibiting/)

## Researcher topics

- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [Mesenchymal stem cell research](https://scholariq.org/topics/mesenchymal-stem-cell-research/)
- [Long-Term Effects of COVID-19](https://scholariq.org/topics/long-term-effects-of-covid-19/)
- [SARS-CoV-2 and COVID-19 Research](https://scholariq.org/topics/sars-cov-2-and-covid-19-research/)
- [Cancer-related molecular mechanisms research](https://scholariq.org/topics/cancer-related-molecular-mechanisms-research/)

## Researcher university

- [Nanchang University](https://scholariq.org/institutions/nanchang-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.